好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Selective Vibration Sensory Deficit in Patients With Motion Sickness
Neuro-ophthalmology/Neuro-otology
P2 - Poster Session 2 (11:45 AM-12:45 PM)
17-017
To determine the prevalence of selective sensory vibration deficits in people susceptible to motion sickness.

Motion sickness (MSK) is a latent neurologic disorder, active only when the vestibular-cortical pathways are disrupted.  It is associated with migraines though the nature and cause of the disorder remain unclear. Patients with MSK are considered to have normal neurological exams. We have identified a selective vibratory deficit in children and adults with motion sickness at rest, present even in the absence of acute symptoms.

This is a 10-year chart review of children and adult patients and family members with MSK.  Each subject had a complete sensory examination as part of their neurologic evaluation. Vibration sensation was tested in both upper and lower extremities and was compared between patient and examiner.  Often, the subject noted loss of vibration, while the examiner still felt active vibration. Results were compared to a control group of children and adults with no migraines or MSK.  Adult subjects were excluded if they had chronic inflammation or degenerative disc disease.

We reviewed the records of 132 adults, ages 18-60 years old, and 59 children, ages 5-17 years old, who experienced MSK. In the adult group with MSK alone, 80% head tuning fork abnormalities detected in their lower extremities. This occurred at rest and not during acute exacerbation of MSK.  In the pediatric group with MSK alone, 63% showed tuning fork abnormalities. MSK onset was mainly in childhood. MSK was present in 68% of adults with migraines (n=233), though a similar pairing in children and teenagers was less common.

Selective vibration sensory deficits were present in most children and adults with MSK at rest. This is a novel clinical finding which suggests involvement of central activation pathways, similar to migraines.

Authors/Disclosures
sydney niesen
PRESENTER
Ms. niesen has nothing to disclose.
Lillian Bower Ms. Bower has nothing to disclose.
Charles E. Niesen, MD (AMS Neurology, Inc.) The institution of Dr. Niesen has received research support from Brain Foundation. Dr. Niesen has received intellectual property interests from a discovery or technology relating to health care.